Internal Medicine Alert – July 15, 2021

July 15, 2021

• The Effect of Antiviral Drugs on COVID-19 Outcomes and Mortality

  The WHO Solidarity Trial Consortium found remdesivir, hydroxychloroquine, lopinavir, and interferon regimens produced “little or no effect” on relevant outcomes.

  Read more about The Effect of Antiviral Drugs on COVID-19 Outcomes and Mortality - Internal Medicine Alert – July 15, 2021

• Air Filters and Asthma

  Children with asthma showed improved small airway mechanics following indoor filtration of particulates (2.5 µm and greater) using high-efficiency particulate air filtration devices.

  Read more about Air Filters and Asthma - Internal Medicine Alert – July 15, 2021

• Using Procalcitonin to Limit Antibiotic Treatment for Sepsis Reduces Infection-Related Adverse Events

  By shortening the duration of antibiotic therapy, a procalcitonin-guided protocol decreased the rate of infection-associated adverse effects, decreased costs, and reduced mortality in patients with sepsis.

  Read more about Using Procalcitonin to Limit Antibiotic Treatment for Sepsis Reduces Infection-Related Adverse Events - Internal Medicine Alert – July 15, 2021

• Aducanumab-avwa Injection (Aduhelm)

  The FDA has approved a new, but controversial, treatment for Alzheimer’s disease.

  Read more about Aducanumab-avwa Injection (Aduhelm) - Internal Medicine Alert – July 15, 2021

• Determining the ‘Culprit’ Artery

  How would one interpret the ECG in the figure, obtained in the ED from a middle-aged man with new chest pain?

  Read more about Determining the ‘Culprit’ Artery - Internal Medicine Alert – July 15, 2021